{
  "success": true,
  "enriched": 54,
  "total_entities": 1505,
  "by_type": {
    "StudyArm": 1,
    "EligibilityCriterion": 31,
    "Objective": 11,
    "Endpoint": 11
  },
  "enriched_items": [
    {
      "type": "StudyArm",
      "name": "ALXN1840 Repeat-Dose Treatment (15 mg/day with titration to 30 mg/day)",
      "arm_type": "Experimental Arm",
      "nci_code": "C174266"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Age",
      "category": "Inclusion",
      "nci_code": "C25532"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Diagnosis of Wilson disease",
      "category": "Inclusion",
      "nci_code": "C25532"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Investigator benefit assessment",
      "category": "Inclusion",
      "nci_code": "C25532"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Ability to comply with study procedures",
      "category": "Inclusion",
      "nci_code": "C25532"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Ability to reside in CRU",
      "category": "Inclusion",
      "nci_code": "C25532"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Discontinue chelator therapy prior to in",
      "category": "Inclusion",
      "nci_code": "C25532"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Adequate venous access",
      "category": "Inclusion",
      "nci_code": "C25532"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Swallow intact tablets",
      "category": "Inclusion",
      "nci_code": "C25532"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Avoid minerals containing copper, zinc, ",
      "category": "Inclusion",
      "nci_code": "C25532"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Diet adherence",
      "category": "Inclusion",
      "nci_code": "C25532"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Contraception requirements",
      "category": "Inclusion",
      "nci_code": "C25532"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Informed consent",
      "category": "Inclusion",
      "nci_code": "C25532"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Decompensated cirrhosis or MELD score ex",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Modified Nazer score exclusion",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Gastrointestinal bleed exclusion",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "ALT exclusion",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Marked neurological disease exclusion",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Hemoglobin exclusion",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Viral infection exclusion",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Significant disorders or psychiatric dis",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Prior ALXN1840/tetrathiomolybdate exclus",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Prior zinc treatment exclusion",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Experimental therapy exclusion",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Renal failure exclusion",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Pregnancy/breastfeeding exclusion",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Sensitivity to ALXN1840 exclusion",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Non-compliance/uncooperative exclusion",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Illicit drug/alcohol abuse history exclu",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Positive urine drug toxicology screen ex",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Alcohol consumption/breath test exclusio",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Unwilling to complete meals/tolerate con",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "Objective",
      "name": "Primary",
      "level": "Trial Primary Objective",
      "nci_code": "C85826"
    },
    {
      "type": "Objective",
      "name": "Secondary",
      "level": "Trial Secondary Objective",
      "nci_code": "C85827"
    },
    {
      "type": "Objective",
      "name": "Secondary",
      "level": "Trial Secondary Objective",
      "nci_code": "C85827"
    },
    {
      "type": "Objective",
      "name": "Secondary",
      "level": "Trial Secondary Objective",
      "nci_code": "C85827"
    },
    {
      "type": "Objective",
      "name": "Secondary",
      "level": "Trial Secondary Objective",
      "nci_code": "C85827"
    },
    {
      "type": "Objective",
      "name": "Secondary",
      "level": "Trial Secondary Objective",
      "nci_code": "C85827"
    },
    {
      "type": "Objective",
      "name": "Secondary",
      "level": "Trial Secondary Objective",
      "nci_code": "C85827"
    },
    {
      "type": "Objective",
      "name": "Safety",
      "level": "Trial Secondary Objective",
      "nci_code": "C85827"
    },
    {
      "type": "Objective",
      "name": "Exploratory",
      "level": "Trial Exploratory Objective",
      "nci_code": "C163559"
    },
    {
      "type": "Objective",
      "name": "Exploratory",
      "level": "Trial Exploratory Objective",
      "nci_code": "C163559"
    },
    {
      "type": "Objective",
      "name": "Exploratory",
      "level": "Trial Exploratory Objective",
      "nci_code": "C163559"
    },
    {
      "type": "Endpoint",
      "name": "Mean daily copper balance",
      "level": "Primary Outcome Measure",
      "nci_code": "C98772"
    },
    {
      "type": "Endpoint",
      "name": "Change in mean daily copper balance",
      "level": "Secondary Outcome Measure",
      "nci_code": "C98781"
    },
    {
      "type": "Endpoint",
      "name": "Copper disposition measures",
      "level": "Secondary Outcome Measure",
      "nci_code": "C98781"
    },
    {
      "type": "Endpoint",
      "name": "Molybdenum disposition measures",
      "level": "Secondary Outcome Measure",
      "nci_code": "C98781"
    },
    {
      "type": "Endpoint",
      "name": "Mean daily molybdenum balance",
      "level": "Secondary Outcome Measure",
      "nci_code": "C98781"
    },
    {
      "type": "Endpoint",
      "name": "Accumulation of molybdenum",
      "level": "Secondary Outcome Measure",
      "nci_code": "C98781"
    },
    {
      "type": "Endpoint",
      "name": "PK parameters for plasma total and PUF-molybdenum",
      "level": "Secondary Outcome Measure",
      "nci_code": "C98781"
    },
    {
      "type": "Endpoint",
      "name": "Safety parameters",
      "level": "Secondary Outcome Measure",
      "nci_code": "C98781"
    },
    {
      "type": "Endpoint",
      "name": "Assess dose response of ALXN1840 on copper balance",
      "level": "Exploratory Outcome Measure",
      "nci_code": "C98724"
    },
    {
      "type": "Endpoint",
      "name": "Effect of time following initiation on copper bala",
      "level": "Exploratory Outcome Measure",
      "nci_code": "C98724"
    },
    {
      "type": "Endpoint",
      "name": "Ceruloplasmin, ceruloplasmin-bound copper, and LBC",
      "level": "Exploratory Outcome Measure",
      "nci_code": "C98724"
    }
  ],
  "cache_stats": {
    "total_entries": 50,
    "fresh_entries": 38,
    "stale_entries": 12,
    "cache_file": "C:\\Users\\panik\\Documents\\GitHub\\Protcol2USDMv3\\core\\evs_cache\\nci_codes.json"
  }
}